These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16167290)

  • 1. Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: effect of sodium naproxen.
    Russo P; Papa V; Russo S; Di Bella A; Pabst G; Milazzo G; Balestrazzi A; Caporossi A;
    Eur J Ophthalmol; 2005; 15(5):598-606. PubMed ID: 16167290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: Effect of sodium naproxen.
    Russo P; Papa V; Russo S; Di Bella A; Pabst G; Milazzo G; Balestrazzi A; Caporossi A; The Naproxen Study Group F
    Eur J Ophthalmol; 2005 Sep - Oct 2005; 15(5):598-606. PubMed ID: 28221461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
    Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J
    Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen ophthalmic solution to manage inflammation after phacoemulsification.
    Papa V; Milazzo G; Santocono M; Servolle V; Sourdille P; Santiago PY; Darondeau J; Cassoux N; LeHoang P
    J Cataract Refract Surg; 2002 Feb; 28(2):321-7. PubMed ID: 11821217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
    Baiza-Duran LM; Quintana-Hau J; Tornero-Montaño R; Ortiz MI; Castañeda-Hernández G; Alanis-Villarreal L; Avalos-Urzua G; Bustos-Zermeño R; Domene-Hinojosa JL; Gómez-Bastar P; Ibañez-Hernandez MA; Morales-Gómez ME; Velasco-Gallegos G; Villar-Kuri J
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
    Cagini C; Pellegrino A; Cerquaglia A; Iaccheri B; Lupidi M; Fiore T
    Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery.
    Demco TA; Sutton H; Demco CJ; Raj PS
    Eur J Ophthalmol; 1997; 7(3):236-40. PubMed ID: 9352276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
    Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
    Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation.
    Diestelhorst M; Schmidl B; Konen W; Mester U; Raj PS
    J Cataract Refract Surg; 1996; 22 Suppl 1():788-93. PubMed ID: 9279673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study.
    Solomon KD; Vroman DT; Barker D; Gehlken J
    J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.